Headquartered in France, Scient'x was founded in 1988 and is a leader in dynamic stabilization and motion preservation spinal implants. Motion preservation is an emerging multi-billion dollar market and represents the largest opportunity in the spinal implant market today. Scient'x is the leading independent spine device company in Europe and possesses an increasingly strong position in the United States. The Company has built a complete line of spinal implants surrounding this core technology and entered the United States market in 2002 with the FDA clearance of its flagship IsoBar® TTL product. Scient'x recently announced that its second-generation cervical disc prosthesis has been implanted in 1,000 patients worldwide. In addition, Scient'x has a range of innovative fusion products including the line of Surgiview products in Europe and Asia.

http://www.scientx.com

Alphatec is one of the largest independent manufacturers of spine surgery implants in the United States. Alphatec addresses one of the highest growth sectors in the orthopedics industry by offering a broad product portfolio and pipeline focused on the cervical, thoracolumbar, intervertebral, minimally invasive, motion preservation, vertebral compression fracture and allograft markets. In addition to its U.S. operations, Alphatec also markets a range of spine and orthopedic products in Asia through its subsidiary, Alphatec Pacific, Inc. Since the firm's March 2005 acquisition, Alphatec has attracted world-class management talent, expanded its infrastructure and manufacturing capabilities and more than quadrupled its revenues from $17M to $80M. In June 2006, Alphatec completed an $84 million initial public offering (NASDAQ: ATEC), and the Company raised an additional $32.2M through a subsequent public offering in September 2007.

http://www.alphatecspine.com

BioHorizons, Inc. is positioned to become the leader in implant dentistry as the only company with a complete product offering, and it will soon become the first company in the industry to market and brand an integrated solution. The Company will leverage the digital technology experience at its dental laboratories to create a revolutionary business model in the industry, streamlining a highly fragmented process to create efficiency, cost savings, and superior patient outcomes. BioHorizons, Inc. is headquartered in Birmingham, Alabama, and has a total of 21 facilities worldwide. The senior management team includes Steve Boggan, CEO, Wallace Sholdice, President, and Todd Strong, Chief Operating Officer, with 35 years of combined dental experience. They have successfully led and integrated 4 transactions while at BioHorizons, which have increased headcount from 112 employees to more than 1,000. These managers are visionaries within the industry, and are executing on a strategy that is transforming implant dentistry.

http://www.biohorizons.com

Nexa Orthopedics, Inc. was founded in 2004 by HealthpointCapital to create the pre-eminent company in extremities surgery through a program of business investments, technology in-licensing, internal development and acquisition. The investment opportunity in the highly fragmented market is based on consolidation and scale driven by differentiated technology. In February 2005, Nexa acquired Futura Biomedical, LLC. Futura manufactures and distributes the only complete line of forefoot arthroplasty products and is a leading innovator of implants for the correction of flexible flatfoot deformities. In the summer of 2005, Nexa acquired the StayFuse™ product line from Pioneer Surgical. Nexa also partnered with OsteoBiologics, Inc. for US distribution of OBI products in hand, foot and ankle surgery. In November 2005, Nexa acquired BioProfile S.A., a French manufacturer of orthopedic extremity products utilizing its novel pyrocarbon. In September 2006, Nexa acquired Axiom Orthopaedics, Inc., a leading innovator in the shoulder arthroplasty market.

HealthpointCapital, LLC sold Nexa Orthopedics, Inc. to Tornier in February 2007. The sale of Nexa provided HealthpointCapital Partners, L.P. a 75% internal rate of return on its investment.

http://www.nexaortho.com/